Lessa Sergio, Pontello João, Duarte Deilton, Lobão Diogo
Division of Plastic Surgery, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Aesthet Surg J Open Forum. 2021 Nov 20;4:ojab048. doi: 10.1093/asjof/ojab048. eCollection 2022.
Many techniques have been presented for the treatment of lower eyelid festoons, but no singular technique has become dominant.
The authors describe the safety and efficacy of intralesional tetracycline injection, the pinch technique, and canthopexy for the treatment of severe festoons.
Institutional board review approval was obtained, and a retrospective chart review was performed on 15 consecutive patients who had received 2% tetracycline injections to treat lower eyelid large festoons between February 2017 and February 2020. Three months after the last injection, a series of patients underwent the surgical procedure: pinch technique and canthopexy bilaterally.
Clinical and photographic records were reviewed, and 12 patients were included in the analysis. Three patients did not return for follow-up after the injection series. Of the 12 patients, there were 3 male patients and 9 female patients, with an average age of 66.6 years. The mean volume injected in each festoon was 0.43 mL, and the mean follow-up was 313 days. A series of injections with a 3-month time interval were performed for patients with a partial response to the initial injection. There was no evidence of complications at the site of the injection. Three months after the last injection, these 12 patients underwent complementary surgical treatment, which included pinch resection and canthopexy.
These preliminary results suggest that intralesional injections of tetracycline 2% may offer a safe option to treat lower eyelid festoons. This noninvasive procedure represents adjunct benefits to complementary surgical therapy.
目前已有多种治疗下睑袋状畸形的技术,但尚无一种技术占据主导地位。
作者描述病灶内注射四环素、捏皮技术和眦固定术治疗重度睑袋的安全性和有效性。
获得机构审查委员会批准,对2017年2月至2020年2月期间连续15例接受2%四环素注射治疗下睑大睑袋的患者进行回顾性病历审查。最后一次注射后三个月,一系列患者接受了手术:双侧捏皮技术和眦固定术。
对临床和照片记录进行了审查,12例患者纳入分析。3例患者在注射系列后未返回进行随访。12例患者中,男性3例,女性9例,平均年龄66.6岁。每个睑袋的平均注射量为0.43 mL,平均随访时间为313天。对初次注射部分反应的患者进行了一系列间隔3个月的注射。注射部位无并发症证据。最后一次注射后三个月,这12例患者接受了补充手术治疗,包括捏皮切除和眦固定术。
这些初步结果表明,病灶内注射2%四环素可能为治疗下睑袋状畸形提供一种安全的选择。这种非侵入性手术对补充手术治疗具有辅助益处。